A Breakthrough Backed by Clinical Evidence The FDAs decision was supported by data from the OASIS 4 Phase 3 clinical trial , which followed 307 adults without diabetes over a 64-week period
Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, et al
SGLT2, sodiumglucose transporter 2
Glomerular, efferent arteriolar, peritubular capillary, and tubular pressures in hypertension
The fatigue usually improves within a few weeks as your body adjusts to operating on fewer calories
Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis